A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia

Status:
Terminated

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety of BMS-852927 after 28 days of dosing in patients with high cholesterol.

Phase 1

Bristol-Myers Squibb